1. Home
  2. Julie Kanter, MD

Director, UAB Adult Sickle Cell Clinic
Co-director, UAB Comprehensive Sickle Cell Disease Center
Department of Medicine – Hematology & Oncology
University of Alabama at Birmingham

1802 6th Avenue, South | North Pavilion, Room 2512
Birmingham, AL 35294
contact address
https://scholars.uab.edu/display/jkanter

Biosketch:

Julie Kanter, MD is the director of the UAB Adult Sickle Cell Clinic, co-director of the Lifespan Comprehensive Sickle Cell Center, and associate professor in the Division of Hematology and Oncology. Her clinical and research interests in sickle cell disease include improving access to care for affected individuals, and identifying and developing novel therapies for sickle cell disease, as well as enhancing horizontal care for patients with sickle cell disease. Kanter comes to UAB from the Medical University of South Carolina, where she was director of sickle cell disease research. Kanter also co-directs the UAB Comprehensive Sickle Cell Disease Center.

Declared conflicts of interest on file (09/15/2021)

Selected Bibliography:

DiMartino LD, Baumann AA, Hsu LL, Kanter J, Gordeuk VR, Glassberg J, Treadwell MJ, Melvin CL, Telfair J, Klesges LM, King A, Wun T, Shah N, Gibson RW, Hankins JS.
The sickle cell disease implementation consortium: Translating evidence-based guidelines into practice for sickle cell disease.
Am J Hematol. 2018;93(12):E391-E395. PubMed abstract / Full Text

Mihalopoulos NL, Phillips TM, Slater H, Thomson JA, Varner MW, Nanjee MN, Moyer-Mileur LJ.
Validity and reliability of perinatal biomarkers of adiposity after storage as dried blood spots on paper.
Am J Hum Biol. 2011;23(5):717-9. PubMed abstract / Full Text

Kanter J, Abboud MR, Kaya B, Nduba V, Amilon C, Gottfridsson C, Rensfeldt M, Leonsson-Zachrisson M.
Ticagrelor does not impact patient-reported pain in young adults with sickle cell disease: a multicentre, randomised phase IIb study.
Br J Haematol. 2019;184(2):269-278. PubMed abstract / Full Text

Cabana MD, Kanter J, Marsh AM, Treadwell MJ, Rowland M, Stemmler P, Bardach NS.
Barriers to Pediatric Sickle Cell Disease Guideline Recommendations.
Glob Pediatr Health. 2019;6:2333794X19847026. PubMed abstract / Full Text

Dowling MM, Quinn CT, Ramaciotti C, Kanter J, Osunkwo I, Inusa B, Iyer R, Kwiatkowski JL, Johnson C, Rhodes M, Owen W, Strouse JJ, Panepinto JA, Neumayr L, Sarnaik S, Plumb PA, Dlamini N, Kirkham F, Hynan LS.
Increased prevalence of potential right-to-left shunting in children with sickle cell anaemia and stroke.
Br J Haematol. 2017;176(2):300-308. PubMed abstract / Full Text